A high-performance liquid chromatography method for the determination of carbamazepine and carbamazepine-10,11-epoxide and its comparison with chemiluminescent immunoassay

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 4, 2009, Pages 458-463

  Leite, Carlos Eduardo ^a   Petersen, Guilherme Oliveira ^a   Lunardelli, Adroaldo ^a   Thiesen, Flavia Valladão ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Carbamazepine; Carbamazepine 10,11 epoxide; Chemiluminescence immunoassay; High performance liquid chromatography; Therapeutic drug monitoring

Indexed keywords

CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE;

ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG MONITORING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; ULTRAVIOLET RADIATION;

CARBAMAZEPINE; CHEMILUMINESCENT MEASUREMENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; IMMUNOASSAY; LINEAR MODELS; SENSITIVITY AND SPECIFICITY;

EID: 63849250633     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.105     Document Type: Article

References (22)

1. Oh E, Ban E, Woo JS, Kim CK. Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography. Anal Bioanal Chem 2006;386:1931-6.
2. Yoshida S, Okada M, Zhu G, Kaneko S. Carbamazepine prevents breakdown of neurotransmitter release induced by hyperactivation of ryanodine receptor. Neuropharmacology 2007;52:1538-46.
3. Bialer M, Levy RH, Perucca E. Does carbamazepine have a narrow therapeutic plasma concentration range. Ther Drug Monit 1998;20:56-9.
4. Camara MS, Mastandrea C, Goicoechea HC. Chemometrics-assisted simple UV-spectroscopic determination of carbamazepine in human serum and comparison with reference methods. J Biochem Biophys Methods 2005; 64:153-66.
5. Parant F, Bossu H, Gagnieu MC, Lardet G, Moulsma M. Cross-reactivity assessment of carbamazepine-10,11-epoxide, oxcarbazepine, and 10-hydroxy-carbazepine in two automated carbamazepine immunoassays: PETINIA and EMIT 2000. Ther Drug Monit 2003;25:41-5.
6. Ma CL, Jiao Z, Jie Y, Shi XJ. Isocratic reversed-phase HPLC for simultaneous separation and determination of seven antiepileptic drugs and two of their active metabolites in human plasma. Chromatographia 2007;65: 267-75.
7. Chollet D, Castella E, Combe P, Arnera V. High-speed liquid chromatographic method for the monitoring of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma. J Chromatogr B Biomed Appl 1996;683:237-43.
8. Yoshida T, Imai K, Motohashi S, Hamano S, Sato M. Simultaneous determination of zonisamide, carbamazepine and carbamazepine-10,11-epoxide in infant serum by high-performance liquid chromatography. J Pharm Biomed Anal 2006;41:1386-90.
9. Lee SH, Li M, Suh JK. Determination of carbamazepine by chemiluminescence detection using chemically prepared tris(2,2V-bipyridine)ruthenium(III) as oxidant. Anal Sci 2003;19:903-6.
10. Shen S, Elin RJ, Soldin SJ. Characterization of cross reactivity by carbamazepine 10,11-epoxide with carbamazepine assays. Clin Biochem 2001;34:157-8.
11. Garg SK, Gupta MC, Handu SS, Bhargava VK. Therapeutic drug monitoring of antiepileptic drugs: a preliminary experience. Indian J Pharmacol 2000;32:28-30.
12. Svinarov DA, Pippenger CE. Relationships between carbamazepine-diol, carbamazepine-epoxide, and carbamazepine total and free steady-state concentrations in epileptic patients: the influence of age, sex, and comedication. Ther Drug Monit 1996;18:660-5.
13. Hermida J, Tutor JC. How suitable are currently used carbamazepine immunoassays for quantifying carbamazepine-10,11-epoxide in serum samples? Ther Drug Monit 2003;25:384-8.
14. Khoschsorur GA, Frü hwirth F, Halwachs-Baumann G. Simple and rapid HPLC method for simultaneous determination of multiple antiepileptic drugs in human serum. Chromatographia 2001;54:345-9.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
16. Bhatti MM, Hanson GD, Schultz L. Simultaneous determination of phenytoin, carbamazepine, and 10,11-carbamazepine epoxide in human plasma by highperformance liquid chromatography with ultraviolet detection. J Pharm Biomed Anal 1998;16:1233-40.
17. Patil KM, Bodhankar SL. Simultaneous determination of lamotrigine, phenobarbitone, carbamazepina and phenytoin in human serum by high-performance liquid chromatography. J Pharm Biomed Anal 2005;39:181-6.
18. Vermeij TA, Edelbroek PM. Robust isocratic high performance liquid chromatographic method for simultaneous determination of seven antiepileptic drugs including lamotrigine, oxcarbazepine and zonisamide in serum after solid-phase extraction. J Chromatogr B 2007;857:40-6.
19. Jankowski A, Stefanik W, Dé c E, Laraki N. The simultaneous determination of carbamazepine and diclofenac in biological samples. Ann Acad Med Siles 2006;60:130-3.
20. Anderson GD. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs. Ther Drug Monit 2008;30:173-80.
21. Al-Qudah AA, Hwang PA, Giescrecht E, Soldin SJ. Contribution of carbamazepine-10,11-epoxide to neurotoxicity in epileptic children on polytherapy. Jordan Med J 1991;25:171-7.
22. Potter JM, Donnely A. Carbamazepine 10,11-epoxide in therapeutic drug monitoring. Ther Drug Monit 1998; 20:652.